Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved. A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” seems to suggest these provisions will be extended for another year. However, its exact details have yet to be released.
Read the full article: DEA Signals Readiness to Extend Telehealth and Prescribing Flexibilities for a Fourth Year //
Source: https://bhbusiness.com/2025/11/14/dea-signals-readiness-to-extend-telehealth-and-prescribing-flexibilities-for-a-fourth-year/